Advancing Science
SCRI Oncology Partners conducts clinical trials through their affiliation with Sarah Cannon Research Institute (SCRI), a global leader in oncology research that has been offering and managing clinical trials in the community for more than 30 years. Since its inception, SCRI has contributed to pivotal research that has helped advance the majority of new cancer therapies approved by the FDA today.
Internationally recognized experts with decades of experience
Advancing care for
all people with cancer
Personalized and
innovative treatments
SCRI Oncology Partners cares for people facing cancer whether newly diagnosed, previously treated, or seeking additional opinions in care or research.
We have access to clinical trials designed to bring the most advanced science to patients in the community, and our specialized and dedicated team provides care for:
• Breast
• Central Nervous System
• Gastrointestinal (Colon, Rectal, Esophageal, Gastric, Liver, Biliary, Pancreatic)
• Genitourinary (Bladder, Kidney, Prostate, Testicular/Germ Cell)
• Gynecologic (Ovarian, Fallopian, Uterine, Cervical, Vulvar)
• Head and Neck
• Lung (Non-Small-Cell, Small-Cell, Mesothelioma)
• Melanoma (Uveal, Cutaneous, Mucosal) Basal Cell, Squamous
• Neuroendocrine and Adrenal
• Sarcoma
• Thyroid, Thymoma/Thymic
• Unknown Primary
Our Services
People facing cancer should have access to the latest treatment options without having to travel far from home, and SCRI Oncology Partners is dedicated to bringing clinical trials and groundbreaking therapies to the communities where people live. We are a cancer treatment center that is led by globally recognized oncologists with disease expertise in cancer care and clinical research. We offer state-of-the-art personalized care and opportunities to participate in clinical trials with innovative treatments.
Location Information
Transforming Care
Meet Our Physicians
SCRI
Oncology Partners
©2023 The US Oncology Network and SCRI Oncology Partners. All rights reserved.
Advancing
Science
Meet Our
Physicians
Our
Services
Contact
Us
More than half of patients reported pain improvement
Highest points awarded for a reduction of inpatient hospital admissions
Continuous reduction of emergency department visits
David R. Spigel, MD
Medical Oncologist, SCRI Oncology Partners Chief Scientific Officer, SCRI
Erika P. Hamilton, MD
Medical Oncologist, SCRI Oncology Partners Director, Breast Cancer Research, SCRI
Ishwaria M. Subbiah, MD
Medical Oncologist, SCRI Oncology Partners
Exec Dir., Cancer Care Equity & Professional Wellness, SCRI
Howard A. “Skip” Burris, III, MD
Medical Oncologist, SCRI Oncology Partners President, SCRI
Melissa L. Johnson, MD
Medical Oncologist, SCRI Oncology Partners Director, Lung Cancer Research, SCRI
Vivek Subbiah, MD
Medical Oncologist, SCRI Oncology Partners
Chief, Early-Phase Drug Development, SCRI
Denise A. Yardley, MD
Medical Oncologist, SCRI Oncology Partners Assistant Director, Breast Cancer Research, SCRI
Meredith A. McKean, MD, MPH
Medical Oncologist, SCRI Oncology Partners
Director, Melanoma & Skin Cancer Research, SCRI
Benjamin Garmezy, MD
Medical Oncologist, SCRI Oncology Partners
Assistant Director, Genitourinary Research, SCRI
Meredith S. Pelster, MD, MSCI
Medical Oncologist, SCRI Oncology Partners
Assistant Director, Gastrointestinal Research, SCRI
SCRI Oncology Partners is led by experts with decades of experience, as well as dedicated staff who specialize in care and research.
• Chemotherapy
• Immunotherapies
• Clinical trials
• Next-generation sequencing
Additionally, SCRI Oncology Partners offers comprehensive cancer care services including:
SCRI Oncology Partners is located at
335 24th Avenue North, Suite 200, Nashville, Tennessee, 37203
Contact Us
To inquire about making an appointment or additional information, please call 615-329-7640 or email cancercareSCRI@usoncology.com.
Contact
Us
Our
Services
Meet Our
Physicians
Advancing
Science
615-329-7640
615-329-7640